Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | GWRE | EMBJ |
|---|---|---|
| Price | $163.23 | $75.27 |
| Change today | ▲ 7.28% | ▲ 0.08% |
| Market cap | $13.38B | $13.39B |
| Return, 3 months | +19.1% | +14.3% |
| Return, year to date | -18.8% | +18.4% |
| Return, 1 year | -29.9% | +30.9% |
| P/E (TTM) | 100.1 | 30.5 |
| P/B | 11.2 | 3.9 |
| P/E percentile vs own 5y | – | 64th |
| Dividend yield | – | 1.04% |
| Revenue growth (YoY, latest qtr) | – | +22.9% |
| Net profit growth (YoY) | – | +208.7% |
| Gross margin | – | 17.9% |
| Operating margin | – | 8.9% |
| Net margin | – | 5.3% |
| Return on equity | – | 13.1% |
| Analyst target vs. price | – | +19.6% |
| Analyst buy share | – | 83% |
| RSI (14) | 55 | 52 |
| 30-day volatility | 88.8% | 24.3% |
| Max drawdown, 1 year | -59.6% | -32.2% |
| Trend read | Strong uptrend | Leaning bullish |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
